plus 3, Breast Cancer Bracelets Nixed at School - Momlogic.com |
- Breast Cancer Bracelets Nixed at School - Momlogic.com
- Breast Cancer Treatment in Large, Fewer Doses of Radiotherapy Lessens ... - PR Inside
- Few Women Take Tamoxifen to Prevent Breast Cancer - WebWire
- Breast cancer virtually "eradicated" with higher levels of vitamin D - Natural News.com
| Breast Cancer Bracelets Nixed at School - Momlogic.com Posted: 08 Feb 2010 10:03 AM PST Message from fivefilters.org: If you can, please donate to the full-text RSS service so we can continue developing it. A controversial awareness campaign has school officials upset. Chances are your kid spends plenty time on Facebook and not nearly enough supporting breast cancer. That's not the case at Santa Clara Middle School in California where middle school students (including boys!) have been sporting breast cancer awareness bracelets, trading and collecting them -- up until school officials banned them from school grounds. Why? The plastic wristbands bear slogans, such as "I Love Boobies" and "Keep a Breast." Santa Clara school board member Andrew Ratermann defended the school's stance by telling ABC News that the purpose of the wristband is to simply get people riled up. "We would be fully supportive of the concept of wanting to do something about breast cancer. But, I think the makers of the bracelets chose intentionally to start a controversy because of the words they used." But kids and parents see things differently since a portion of the bracelet sales support breast cancer charities. According to parents the wristbands allow kids to honor those who have died from cancer and also raise awareness about a serious disease in a non-scary, relatable way. Karen Garaci, the mother of a 13-year-old daughter at the school, told ABC News: "I completely support it. I don't want my daughter to die of breast cancer. I thought it was a fun message and I thought it would get the awareness out in an easy way. Instead of saying, 'Look, breast cancer's going to kill you. Do your exams.' Here, I love boobies. Let's save them and make it approachable for her age group." Her daughter, 13 year-old Sarah Garaci does not want to take hers off. "One of my other teachers, I asked her, 'What do you think of the bracelet?' She told me it was demeaning and offensive, and people were making fun of breast cancer," says Sarah. "I'm still going to wear the bracelet. It actually has a good cause to it. It has a good meaning." Tell us: Do you think it's OK to make breast cancer awareness a hip topic to appeal to kids? Five Filters featured article: Chilcot Inquiry. Available tools: PDF Newspaper, Full Text RSS, Term Extraction. |
| Breast Cancer Treatment in Large, Fewer Doses of Radiotherapy Lessens ... - PR Inside Posted: 08 Feb 2010 09:06 AM PST Message from fivefilters.org: If you can, please donate to the full-text RSS service so we can continue developing it. 2010-02-08 18:07:16 -
The study found that women who received the larger doses experienced less skin changes than those subjected to the normal dose. These larger, less-frequent doses also reduce the total amount of radiation delivered over the course of the breast cancer treatment.Meg McArthur, from the Breakthrough Breast Cancer charity, told The Telegraph: "Radiotherapy is important in reducing the chance of cancer coming back but women have told Breakthrough that attending many sessions can be both physically and emotionally draining. Anything that has the potential to deliver radiotherapy treatment in a way that could benefit a patient's quality of life is to be welcomed." Read more about this story at Breast Cancer News Today:
Latest Radiation Therapy news - breastcancer.einnews.com/news/radiation-therapy-breast-cancer Located at breastcancer.einnews.com, Breast Cancer News Today is a service of EIN News, an industry leader in news monitoring for business professionals and analysts. Using a combination of proprietary search technology and human editing, EIN News delivers to its members the latest breast cancer news from around the world, saving them valuable time they'd spend searching for information. New users to Breast Cancer News Today can enjoy a no-obligation, one-week free trial.
About EIN Presswire
Five Filters featured article: Chilcot Inquiry. Available tools: PDF Newspaper, Full Text RSS, Term Extraction. |
| Few Women Take Tamoxifen to Prevent Breast Cancer - WebWire Posted: 08 Feb 2010 07:40 AM PST Message from fivefilters.org: If you can, please donate to the full-text RSS service so we can continue developing it. • Less than a quarter of one percent of women took tamoxifen in 2000 and 2005 to prevent breast cancer. PHILADELPHIA – Researchers with the National Cancer Institute (NCI) have found that the prevalence of tamoxifen use for the prevention of breast cancer among women without a personal history of breast cancer is very low. Tamoxifen can reduce the risk of developing breast cancer in women who are at increased risk for developing the disease. Details of this survey are published in the February issue of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. The low prevalence of tamoxifen use may stem from various sources, which were not investigated in this study, according to the study's coauthor Andrew N. Freedman, Ph.D., chief of the Clinical and Translational Epidemiology Branch, Division of Cancer Control and Population Sciences, NCI. However, he stressed that "counseling individual women about using tamoxifen to prevent breast cancer must include a patient's discussion with her physician about the drug's risks and benefits, as well as consideration of the patient's personal values, preferences, lifestyle and specific medical situation." Lead author of this study Erika A. Waters, Ph.D., M.P.H., assistant professor at Washington University School of Medicine in St. Louis, and colleagues at the NCI wanted to gain an understanding of how many women aged 40 to 79 years were taking tamoxifen for the prevention of breast cancer. They answered this question using data from the National Health Interview Surveys from years 2000 and 2005, which are nationwide surveys designed to be representative of the entire United States. The surveys included more than 10,000 women for each year. "Our results indicated that very few women were using tamoxifen to prevent breast cancer," said Waters. "However, we don't know exactly why." The researchers found that the prevalence of tamoxifen use in this survey population was very low — 0.2 percent in 2000 and 0.08 percent in 2005. The difference between the two years was not statistically meaningful, according to the researchers. Freedman and Waters speculated that the drug's low uptake may be linked to many factors including the fact that tamoxifen is associated with several side effects. These side effects include hot flashes, sexual problems, uterine cancer, blood clots and cataracts. Other possible explanations that the researchers gave for the low uptake may be that physicians are unaware of the drug's availability, physicians are reluctant to prescribe it, patients are reluctant to take it, there is a lack of patient or physician education about the drug, or skepticism about whether the benefits outweigh the risks. It could also be that physicians and patients are, in fact, very educated and are making very informed decisions, according to the researchers. "The decision to use a drug like tamoxifen in women at high-risk for, but who do not yet have a diagnosis of breast cancer is not easy. It is dependent upon the woman's personal choice, which can be influenced by many factors, not just her medical eligibility. There is no right answer," said Waters, who at the time of the study was a fellow in the Cancer Prevention Fellowship Program, Center for Cancer Training, NCI. Susan Gapstur, Ph.D., M.P.H., vice president of epidemiology, American Cancer Society, and editorial board member of Cancer Epidemiology, Biomarkers & Prevention, said that "overall, these results provide an important snapshot of the very low uptake of tamoxifen for cancer prevention." "Although the researchers speculate on a number of possible explanations, it remains unclear to what extent the low uptake might be attributed to physician reluctance to prescribe tamoxifen and/or patient reluctance to take it," said Gapstur. # # # The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes 30,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and nearly 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowship and career development awards. The AACR Annual Meeting attracts more than 16,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes six major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy. WebWireID112270
News Release Distribution and Press Release Distribution Services Provided by WebWire. Five Filters featured article: Chilcot Inquiry. Available tools: PDF Newspaper, Full Text RSS, Term Extraction. This posting includes an audio/video/photo media file: Download Now |
| Breast cancer virtually "eradicated" with higher levels of vitamin D - Natural News.com Posted: 08 Feb 2010 12:12 PM PST Message from fivefilters.org: If you can, please donate to the full-text RSS service so we can continue developing it. 
(NaturalNews) In a gathering of vitamin D researchers recently held in Toronto, Dr. Cedric Garland delivered a blockbuster announcement: Breast cancer can be virtually "eradicated" by raising vitamin D levels. Vitamin D is "the cure" for breast cancer that the cancer industry ridiculously claims to be searching for. The cure already exists! But the breast cancer industry simply refuses to acknowledge any "cure" that doesn't involve mammography, chemotherapy or high-profit pharmaceuticals. Vitamin D is finally gaining some of the recognition it deserves as a miraculous anti-cancer nutrient. It is the solution for cancer prevention. It could save hundreds of thousands of lives each year in the U.S. alone. Even Dr. Andrew Weil recently raised his recommendation of vitamin D to 2,000 IU per day. This is the vitamin that could destroy the cancer industry and save millions of women from the degrading, harmful cancer "treatments" pushed by conventional medicine. No wonder they don't want to talk about it! The cancer industry would prefer to keep women ignorant about this vitamin that could save their breasts and their lives. Below I'm reprinting the full statement from Dr. Cedric Garland following the Vitamin D conference recently held in Toronto. Breast cancer is a disease so directly related to vitamin D deficiency that a woman's risk of contracting the disease can be 'virtually eradicated' by elevating her vitamin D status to what vitamin D scientists consider to be natural blood levels.That's the message vitamin D pioneer Dr. Cedric Garland delivered in Toronto Tuesday as part of the University of Toronto School of Medicine's "Diagnosis and Treatment of Vitamin D Deficiency" conference - the largest gathering of vitamin D researchers in North America this year. More than 170 researchers, public health officials and health practitioners gathered at the UT Faculty club for the landmark event. Garland's presentation headlined a conference that reviewed many aspects of the emerging vitamin D research field - a booming discipline that has seen more than 3,000 academic papers this calendar year alone, conference organizers said. That makes vitamin D by far the most prolific topic in medicine this year, with work connecting it with risk reduction in two dozen forms of cancer, heart disease, multiple scleroses and many other disorders. Dr. Reinhold Vieth, Associate Professor in the Department of Laboratory Medicine and Pathobiology at University of Toronto, and Director of the Bone and Mineral Laboratory at Mount Sinai Hospital, organized the event in conjunction with Grassroots Health - an international vitamin D advocacy group founded by breast cancer survivor Carole Baggerly. Baggerly implored the research group to take action and encourage Canadians to learn more about vitamin D and to raise their vitamin D levels. An estimated 22,700 women will be diagnosed with breast cancer in 2009, according to the Canadian Cancer Society's latest figures. As much as 97 percent of Canadians are vitamin D deficient at some point in the year, according to University of Calgary research - largely due to Canada's northerly latitudes and weak sun exposure. Sunshine is by far the most abundant source of vitamin D - called 'The Sunshine Vitamin' - with salmon and fortified milk being other sources. Vitamin D supplementation helps raise levels for many as well. Grassroots Health's "D-action" panel - 30 of the world's leading researchers on vitamin D and many other vitamin D supporters - recommend 2,000 IU of vitamin D daily and vitamin D blood levels of 100-150 nanomoles-per-liter as measured by a vitamin D blood test.
Five Filters featured article: Chilcot Inquiry. Available tools: PDF Newspaper, Full Text RSS, Term Extraction. This posting includes an audio/video/photo media file: Download Now |
| You are subscribed to email updates from Add Images to any RSS Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment